Figure 7. Overexpression of ARHGAP27P1 inhibited tumor growth in vivo. (A) Growth curves of tumors from vector or ARHGAP27P1 groups were shown. Tumor volumes were calculated every 3 days. (B) Tumor samples and tumor weights from respective groups were represented. (C) RT-qPCR analysis of ARHGAP27P1, JMJD3, p15, p16 and p57 in xenograft tumors. (D) Histopathology and immunostainings of JMJD3, p15, p16 and Ki-67 in paraffin tumor sections. (E) Representative blots of JMJD3, EZH2, SUZ12, H3K4me3, H3K27me3, p15, p16, and p57 in tumor tissues. *P < 0.05, **P < 0.01 versus vector.